A b s t r a c t Six new p-phthalato binuclear oxovanadium(1V) complexes, namely [(VO)z(PHTH)-(L)2]SO, (L denotes '2,2'-bipyridine (bpy); 1,lO-phenanthroline (phen); 4,4'-dimethyl-2,2'-bipyridine (Mezbpy); 5-nitrcz1 ,lO-phenanthroline (NOZ-phen); 5-chIo~1,lO-phenanthroline (C1-phen) and 5methyl-1,lO-
Synthesis characterization and magnetic properties of μ-iodanilato dinuclear oxovanadium(IV) complexes
✍ Scribed by Yan-Tuan Li; Cui-Wei Yan; Qi-Zhi Zhou; Dai-Zheng Liao
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 418 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0256-7660
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A new series of oxovanadium(IV)–lanthanide(III) heteronuclear complexes [Yb(H~2~O)~8~]~2~[(VO)~2~(TTHA)]~3~⋅21 H~2~O (1), {[Ho(H~2~O)~7~(VO)~2~(TTHA)][(VO)~2~(TTHA)]~0.5~}⋅ 8.5 H~2~O (2), {[Gd(H~2~O)~7~(VO)~2~(TTHA)][(VO)~2~(TTHA)]~0.5~}⋅8.5 H~2~O (3), {[Eu(H~2~O)~7~][(VO)~2~(TTHA)]~1.5
## Abstract Two guanidino acid oxovanadium(IV) complexes have been synthesized. Preliminary tests __in vivo__ have shown that the two title complexes all display lowering glucose activity __in vivo__ to STZ‐rats. The effect of glucose‐lowering of guanidino acetic acid oxovanadium(IV) complex __in v